Calcium D Plus
Natural health product licensed in Canada
- Other names
- Pur Vit Calcium D Plus
- Licence holder
- Cambridge Pharma Inc.
- NPN or DIN-HM
- 80085187
- Status
- Active licence
- Licence date
- 14 May 2018
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Dose déclarée au-delà d'une limite
Manganèse: up to 6 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 3.5 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Cuivre: up to 4,000 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2,000 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Zinc: up to 16 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Manganèse Source : Citrate de manganèse (II) | 3 milligramme | 6,000 µg |
| Calcium Source : Carbonate de calcium | 350 milligramme | 700,000 µg |
| Cuivre Source : Citrate de cuivre (II) | 2 milligramme | 4,000 µg |
| Magnésium Source : Oxyde de magnésium | 50 milligramme | 100,000 µg |
| Sélénium Source : Citrate de sélénium | 2 microgrammes | Not calculated |
| Zinc Source : Citrate de zinc | 8 milligramme | 16,000 µg |
| Vitamine D Source : Cholécalciférol | 10 microgrammes | Not calculated |
Non-medicinal ingredients
Gélatine, Dioxyde de titane, Glycérine, Lécithine, Huile de fève de soja, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Source of/An electrolyte for the maintenance of good health. Calcium intake, when combined with sufficient Vitamin D, a healthy diet and regular exercise may reduce the risk of developing osteoporosis. Helps to maintain proper muscle function, including the heart muscle. Helps to produce and repair connective tissue. Helps in the development and maintenance of bones and teeth. Source of/An antioxidant for the maintenance of good health. Helps to maintain healthy bones, hair, nail and/or skin. Helps to maintain immune function. Helps to maintain the body's ability to metabolize nutrients.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you have a liver disorder, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80085187
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.